Catabasis Pharmaceuticals, Inc. Appoints Henry Rath to Vice President, Business Development  
5/31/2012 10:15:10 AM

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Catabasis Pharmaceuticals, a clinical stage biopharmaceutical company dedicated to the discovery and development of innovative, effective and safe medicines for the treatment of inflammatory and metabolic diseases, today announced the appointment of Henry Rath to the position of vice president, business development. In this new role, Mr. Rath will lead the company’s corporate development strategy.